Clinical Trial Update: Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry

View source ↗

Summary

Completed registry update for Vigilant Observation of Gliadel Wafer Implant Registry documenting the study status and findings to date.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• GLIADEL wafer (carmustine)

Snippet

Sponsor: Arbor Pharmaceuticals, Inc. | Conditions: CNS Tumor | Status: COMPLETED